Navigation Links
Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
Date:4/7/2008

nts of the NIH National Library of Medicine.

In announcing his pending retirement, Dr. Cape commented, "I am pleased to have served on the EntreMed Board during its rebuilding period. The Company has promising programs that are making good progress, but I would now like to spend more time with my family and friends. I wish everyone at EntreMed continued progress."

EntreMed Board Chairman, Michael M. Tarnow commented, "Dr. Cape has been a distinguished member of our Board since he joined in 2003. He has been involved in the biotech industry virtually from the beginning, and he has participated actively in its development since those early days. His valuable contributions to the field of biotechnology and his contribution to EntreMed are hallmarks of his leadership and commitment to the industry. We are honored to have had the opportunity to draw from Dr. Cape's vast knowledge and sage advice. While his service will be missed, we wish him all the best in his retirement."

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1 is currently in multiple Phase 2 clinical trials for cancer. MKC-1 is an oral cell-cycle regulator with activity against the mTOR pathway. ENMD-1198, a novel antimitotic agent, is in a Phase 1 study in advanced cancer patients and ENMD-2076, a selective kinase inhibitor, is expected to begin a Phase 1 study in 2Q08. The Company also has an approved IND application for Panzem(R) in rheumatoid arthritis. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about EntreMed is available on the Company's web site at http://www.entremed.com and in var
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. International Soccer Superstar Ronaldinho Signs With Nutrilite(TM)
2. MCM Completes Westwood Replacement Hospital - Ronald Reagan UCLA Medical Center
3. Philadelphia Ronald McDonald House(R) at Front & Erie Celebrates Grand Opening
4. Mayo Clinics Dr. Ronald C. Petersen Awarded Leon Thal Prize for Excellence in Dementia Research
5. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
6. St. Christophers Foundation For Children Ronald McDonald(R) Care Mobile Making Tri-State Visits to Provide Dental Care to Children at No Cost
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. East Ridge Retirement Village Announces Enhancement Plan
9. Increased Heart Risk Seen for Retired NFL Players
10. Mayo Clinic finds retired NFL players at increased risk for heart problems
11. AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...mosomal change that raises odds for malignancy, st... News) -- Some Japanese survivors of the World War...xperienced key genetic changes that may have spark...arch indicates. , Papillary thyroid cancer (PTC...tion involving the so-called BRAF gene. But Japane...
(Date:8/29/2008)...RNewswire/ -- In response to recent news,about Mic...isease (CWD),members of the deer farming communit...ing season fast approaching, the tragic incident r...County farm understandably has,created concern amo...cross,the great state of Michigan. The deer farmin...
(Date:8/29/2008)... to More Than 30 European Countries, HONOLULU, Au...d today,that it has successfully completed the int...ical Device Directive (for most European Union cou...rk -- or Conformite Europeene Mark,-- for the Life...na,s,patient safety reach to include more than 30 ...
(Date:8/29/2008)...presents Telemedicine Encounter Management Systems...ions as a possible solution to national health car...d, MA (PRWEB) August 29, 2008 -- If there has been...s at the Democratic National Convention it has bee...ional health care issues., , ,Our Democratic leade...
Breaking Medicine News(10 mins):Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2
...ability to speak, communicate and relate to others...ence Autism Speaks, a non-profit organization has ... be created on autism. // It was founded in 2005.... between the patients, doctors, researchers and th...
... M.D., and colleagues say that mutation in CCR5 (c...nfection but increases the risk of developing West...NV) illness is caused due to a mosquito-borne viru...tional Institute of Allergy and Infectious Disease...
...ool in Scotland with the object of preventing chil.... Seminars are proposed to be conducted in schools...e reportedly resulting in the number of skin cance... Thomas Muir High School are reported to be going ...
...colleagues of the University of Texas Health Scien...he rat acts as an anti-depressant. Leptin is a hor...ulation. // The research was done on chronic unpre... that CUS rats had decreased levels of Leptin than...
Other Medicine News:Health News:CCR5 Mutation Confers Immunity Against HIV But Not Against West Nile Virus Illness 2Health News:Leptin, The Next Generation Antidepressant? 2
(Date:8/25/2008).../- Anthera Pharmaceuticals,Inc., a pr...anti-inflammatory drugs, today announced the initi...ry events with Near-term Cardiovascular,Inflammati... the impact of,varespladib when administered to pa...me (ACS) event., The FRANCIS trial is designed to...
(Date:8/22/2008)...al Sponsored by Medical Research Council, LEXINGT...us,Pharmaceuticals, Inc. (Nasdaq: IDEV ) announce...DP 301, a Phase III clinical trial of PRO 2000, th...prevention of HIV and other,sexually transmitted i...ngdom,s Medical Research Council (MRC) and conduct...
(Date:8/22/2008)...Newswire-FirstCall/ -- Human Genome,Sciences, Inc....leted the,enrollment and initial dosing of patient...umumab) in combination with the chemotherapy agent... in advanced non-small cell,lung cancer (NSCLC)., ...416/HGSLOGO ), "There is an urgent medical need ...
(Date:8/21/2008)...RNewswire-USNewswire/ -- A research team,headed by...G. Nagaraja has,been tapped by the U.S. Department...en feeding distillers, grains and E. coli 0157:H7 ...sence of the naturally occurring,pathogen in the a...al Research Initiative in Food,Safety grant. Nagar...
Breaking Medicine Technology:Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers' Grains 2Severely restricted diet linked to physical fitness into old age 956 1Severely restricted diet linked to physical fitness into old age 956 2U S Advisers OK Nasal Spray Flu Vaccine for Young Children 4523 1U S Advisers OK Nasal Spray Flu Vaccine for Young Children 4523 2U S Advisers OK Nasal Spray Flu Vaccine for Young Children 4523 3WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 4520 1WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 4520 2WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 4520 3Blue Cross of California Foundation Donates 2450 000 to American Red Cross 4517 1Blue Cross of California Foundation Donates 2450 000 to American Red Cross 4517 2
The Smith & Nephew ECTRA II systems permit the surgeon to access and release the carpal tunnel ligament endoscopically, allowing access via two portals for distal and proximal cutting, while minimizi
... System provides a unique option for the correctio...arly the opening wedge osteotomy of the first meta...mall Fragment Plate and Screw Set is a complete tr...es the plates, screws, and drills. It provides a m...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d
Medicine Products: